HE3286 Reduces Axonal Loss and Preserves Retinal Ganglion Cell Function in Experimental Optic Neuritis
Open accessThe DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
PURPOSE: Optic nerve inflammation, demyelination, and axonal loss are all prominent features of optic neuritis. While corticosteroids hasten visual recovery in optic neuritis, no treatment improves final visual outcomes. HE3286 (17α-ethynyl-5-androstene-3β,7β,17β-triol), a synthetic derivative of a natural steroid, β-AET (5-androstene-3β,7β,17β-triol), exerts anti-inflammatory effects in several disease models and has purported neuroprotective effects as well. HE3286's ability to suppress optic neuritis was examined in experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. METHODS: Experimental autoimmune encephalomyelitis was induced in C57/BL6 mice. Mice were treated daily with intraperitoneal vehicle or 40 mg/kg HE3286. Visual function was assessed by optokinetic responses (OKR) at baseline and every 10 days until euthanasia at 40 days post immunization. Retinas and optic nerves were isolated. Inflammation (hematoxylin and eosin and Iba1 staining), demyelination (Luxol fast blue staining), and axonal loss (neurofilament staining) were assessed in optic nerve sections. Retinal ganglion cells (RGCs) were immunolabeled with Brn3a antibodies to quantify RGC survival. RESULTS: Progressive decreases in OKR occurred in vehicle-treated EAE mice, and HE3286 treatment reduced the level of this vision loss. HE3286 also attenuated the degree of inflammation, demyelination, and axonal loss in EAE optic nerves as compared to nerves from vehicle-treated EAE mice. Retinal ganglion cell loss that occurred in both vehicle- and HE3286-treated EAE mice was reduced in the temporal retinal quadrant of HE3286-treated mice. CONCLUSIONS: HE3286 suppresses inflammation, reduces demyelination and axonal loss, and promotes RGC survival during experimental optic neuritis. Importantly, HE3286 treatment also preserves some RGC function. Results suggest that HE3286 is a potential novel treatment for optic neuritis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, C. H., O'Connor, P. W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., Lublin, F. D., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,386
Paty, D. W., Li, D. K. B., the UBC MS/MRI Study Group, & the IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.662 · Cited by 1,967
Johnson, K. P., Brooks, B. R., Cohen, J. A., Ford, C. C., Goldstein, J., Lisak, R. P., Myers, L. W., Panitch, H. S., Rose, J. W., Schiffer, R. B., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,898
Parallel processing in the mammalian retina
Wässle, H. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1497 · Cited by 1,252
The fundamental plan of the retina
Masland, R. H. (2001) · Nature Neuroscience · doi:10.1038/nn0901-877 · Cited by 1,237
Hartung, H.-P., Gonsette, R., Konig, N., Kwiecinski, H., Guseo, A., Morrissey, S. P., Krapf, H., & Zwingers, T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)12023-x · Cited by 946
Rapid Quantification of Adult and Developing Mouse Spatial Vision Using a Virtual Optomotor System
Prusky, G. T., Alam, N. M., Beekman, S., & Douglas, R. M. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0541 · Cited by 772
Rodieck, R. W. (1998) · Optometry and Vision Science · doi:10.1097/00006324-199812000-00004 · Cited by 659
(1998) · Cited by 601
Kroboth, P. D., Salek, F. S., Pittenger, A. L., Fabian, T. J., & Frye, R. F. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922007903 · Cited by 518
Cited by
Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies
Buccellato, F. R., D’Anca, M., Tartaglia, G. M., Del Fabbro, M., Scarpini, E., & Galimberti, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813900 · Cited by 94
Reading, C. L., Ahlem, C. N., & Murphy, M. F. (2021) · Neurodegenerative Disease Management · doi:10.2217/nmt-2021-0022 · Cited by 84
Self-citationRetinal Cell Degeneration in Animal Models
Niwa, M., Aoki, H., Hirata, A., Tomita, H., Green, P. G., & Hara, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010110 · Cited by 62
Novel Therapeutics in Glaucoma Management
Bucolo, C., Platania, C. B. M., Drago, F., Bonfiglio, V. M. E., Reibaldi, M., Avitabile, T., & Uva, M. G. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170915142727 · Cited by 54
Boghozian, R., McKenzie, B. A., Saito, L. B., Mehta, N., Branton, W. G., Lu, J., Baker, G. B., Noorbakhsh, F., & Power, C. (2017) · Glia · doi:10.1002/glia.23179 · Cited by 45
Khan, R. S., Dine, K., Geisler, J. G., & Shindler, K. S. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7180632 · Cited by 41
Self-citationLambert, W. S., Carlson, B. J., Formichella, C. R., Sappington, R. M., Ahlem, C., & Calkins, D. J. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00045 · Cited by 31
Self-citationExploring experimental autoimmune optic neuritis using multimodal imaging
Manogaran, P., Walker-Egger, C., Samardzija, M., Waschkies, C. F., Grimm, C., Rudin, M., & Schippling, S. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.04.004 · Cited by 30
Dexras1 Deletion and Iron Chelation Promote Neuroprotection in Experimental Optic Neuritis
Khan, R. S., Baumann, B. H., Dine, K. E., Song, Y., Dunaief, J. L., Kim, S. F., & Shindler, K. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-48087-3 · Cited by 29
Self-citationMonte, M. D., Cammalleri, M., Locri, F., Amato, R., Marsili, S., Rusciano, D., & Bagnoli, P. (2018) · Nutrients · doi:10.3390/nu10030325 · Cited by 27
RetractedExperimental optic neuritis induced by the microinjection of lipopolysaccharide into the optic nerve
Aranda, M. L., Dorfman, D., Sande, P. H., & Rosenstein, R. E. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.01.010 · Cited by 25
Khan, R. S., Dine, K. E., Wessel, H., Brown, L., & Shindler, K. S. (2019) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000760 · Cited by 23
Self-citationMatrine treatment reduces retinal ganglion cell apoptosis in experimental optic neuritis
Kang, J., Liu, S., Song, Y., Chu, Y., Wang, M., Shi, Y., Zhang, F., & Zhu, L. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-89086-7 · Cited by 21
Therapeutic benefit of environmental enrichment on optic neuritis
Aranda, M. L., Fleitas, M. F. G., Diéguez, H. H., Milne, G. A., Devouassoux, J. D., Sarmiento, M. I. K., Chianelli, M. S., Sande, P. H., Dorfman, D., & Rosenstein, R. E. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.017 · Cited by 16
Balzano, T., Esteban-García, N., & Blesa, J. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2160440 · Cited by 13
Castrogiovanni, P., Trovato, F. M., Szychlinska, M. A., Loreto, C., Giunta, S., Scuderi, S., Passanisi, R., Fidone, F., Fagone, P., Imbesi, R., et al. (2016) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk1010069 · Cited by 13
Reading, C. L., Yan, J., Testa, M. A., Simonson, D. C., Javaid, H., Schmunk, L. J., Martin-Herranz, D. E., Brooke, R. T., Gordevičius, J., Zhang, J., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1516746 · Cited by 12
Self-citationControlled blood sugar improves the eye’s accommodative ability in type-1 diabetes
Abokyi, S., Ayerakwah, P. A., Abu, S. L., & Abu, E. K. (2020) · Eye · doi:10.1038/s41433-020-1058-y · Cited by 12
Amnion-Derived Multipotent Progenitor Cells Suppress Experimental Optic Neuritis and Myelitis
Khan, R. S., Ross, A. G., Willett, K. L., Dine, K. E., Banas, R., Brown, L. R., & Shindler, K. S. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00949-9 · Cited by 11
Self-citationStojic, A., Fairless, R., Beck, S. C., Sothilingam, V., Weißgerber, P., Wissenbach, U., Gimmy, V., Seeliger, M. W., Flockerzi, V., Diem, R., et al. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20419 · Cited by 10
Assessing the anterior visual pathway in optic neuritis: recent experimental and clinical aspects
Dietrich, M., Aktaş, O., Hartung, H., & Albrecht, P. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000675 · Cited by 9
Pyka‐Fościak, G., Fościak, M., Pabijan, J., LIS, G. J., Litwin, J. A., & Lekka, M. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166796 · Cited by 8
Faraji, J., Bettenson, D., Yong, V. W., & Metz, G. A. S. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578240 · Cited by 7
“Current and emerging drug therapies in Alzheimer’s disease: A pathophysiological Perspective”
Aparajita, A., Jain, U., & Srivastava, P. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.078 · Cited by 2
Markham, P., Peluso, M. J., Chou, S., McCorkell, L., O’Quinn, S., Reading, C., Ahlem, C. N., Petit, C., Yan, J., & Palumbo, J. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-118726 · Cited by 1
Self-citationMatrine protects retinal ganglion cells from apoptosis in experimental optic neuritisPreprint
Kang, J., Liu, S., Song, Y., Wang, M., Chu, Y., Shi, Y., Zhang, F., Wu, H., & Zhu, L. D. (2020) · Research Square · doi:10.21203/rs.2.13687/v2
Matrine protects retinal ganglion cells from apoptosis in experimental optic neuritisPreprint
Kang, J., Liu, S., Song, Y., Wang, M., Chu, Y., Shi, Y., Zhang, F., Wu, H., & Zhu, L. D. (2019) · Research Square · doi:10.21203/rs.2.13687/v1
Various forms of glaucoma and their treatments
Sharif, N. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-819291-7.00032-0
Sharif, N. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85841-0.00018-3
Tunley, S. (2024) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.25201913
Anti-inflammatory and immunomodulating agents
Britten, J. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30008-0.00014-4
Wang, B., Ganzen, L. C., Coskun, E., James, R., Kha, T., Zhu, X., New, J. A., Tsujikawa, M., & Leung, Y. F. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.18.719270
Metadata
- Authors
- Khan, R. S., Dine, K., Luna, E., Ahlem, C., & Shindler, K. S.
- Affiliations
- University of Pennsylvania (US)
- Harbor Therapeutics, Inc., San Diego, California, United States
- Corresponding author
- Shindler, Kenneth S.
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2014-09-11
- Volume
- 55
- Issue
- 9
- Pages
- 5744
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- PMC
- PMC4161484
- OpenAlex
- W2012637873
- Cited by
- 33
- References
- 41
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 5 · 2016: 2 · 2015: 1
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion, public-domain)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- F. M. Kirby Foundation
- Research to Prevent Blindness
- James N. Kirby Foundation
- National Institutes of Health
- National Eye Institute (R01EY019014, EY019014, P30EY001583)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- optic neuritis, experimental autoimmune encephalomyelitis, retinal ganglion cell survival, axonal loss, demyelination, neuroprotection, anti-inflammatory steroids, multiple sclerosis model, visual function
- MeSH terms
- Animals, Anti-Inflammatory Agents, Axons, Dehydroepiandrosterone, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental, Female, Mice, Inbred C57BL, Optic Neuritis, Retinal Ganglion Cells, Neuroprotective Agents, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.